Anthropic IPO (ANT): can Indian investors buy shares?

Anthropic — the AI company behind the Claude model family — filed its public S-1 prospectus with the SEC on October 26, 2026. Proposed ticker: ANT, NYSE listing. Valuation target: approximately $2 trillion.

If this IPO prices at that valuation, ANT will be one of the largest public offerings in US market history — ranking alongside Aramco, Microsoft, and Apple at their peak valuations. And like every major US IPO, the question from Indian investors is: can I get in at the IPO price?

Short answer: no. But you can buy post-listing — same as any US stock — through any Indian LRS platform. Here's the full picture.

What Anthropic is

Anthropic was founded in 2021 by Dario Amodei (CEO), Daniela Amodei (President), and several colleagues who left OpenAI. The founding thesis was building safer, more interpretable AI systems — hence the focus on "Constitutional AI" and model alignment research alongside commercial products.

Products:

• Claude model family — Claude 3.5 Sonnet, Claude 3 Opus, Claude 4 (latest as of 2026): general-purpose AI models for enterprise and consumer use
• Claude.ai — consumer subscription product competing with ChatGPT
• Claude API — developer and enterprise API; the primary revenue driver
• Anthropic for Enterprise — contracts with regulated industries (finance, healthcare, legal, government) where safety certification matters

Revenue model: API usage fees, enterprise contracts, Claude.ai subscriptions. Revenue not publicly disclosed; analyst estimates range from $3–5B ARR as of late 2026.

Key investors before IPO:

Competitive position: Anthropic competes directly with OpenAI (GPT-4o, o3), Google (Gemini), Meta (Llama open-source), and Mistral. None has established a durable moat. The frontier AI market is a race with no clear winner yet.

The IPO: what we know

Can Indian retail investors buy ANT at the IPO price?

No — and this is not platform-specific. It is structural.

US IPOs work differently from Indian IPOs:

Who gets US IPO allocations:

1. US institutional investors — mutual funds, pension funds, hedge funds that submit orders during the book-building roadshow
2. High-net-worth US brokerage clients — via preferred client access
3. Some US retail investors — via platforms like Robinhood that run retail IPO access programs

Who cannot:

• Indian retail investors with LRS accounts
• Any non-US resident using a standard brokerage account

This is not Vested's limitation or INDmoney's limitation. No Indian LRS platform can offer US IPO allocations. Standard US brokerage accounts (DriveWealth, Alpaca) are not qualified for IPO book-building participation.

The Indian IPO grey market analogy does not apply. There is no "GMP" or unofficial pre-IPO market for US IPOs in the way there is for Indian IPOs. Secondary market platforms like Forge Global exist but are for US accredited investors — not accessible via Indian LRS accounts.

After listing: Once ANT begins trading on NYSE, it is a regular listed US equity. Any Indian investor with a funded LRS account can buy ANT — including fractional shares — exactly as they would buy Apple or Nvidia.

How to buy ANT post-listing from India: step by step

Step 1: Open an LRS account

If you don't have a US brokerage account via an Indian platform, open one now — KYC takes 3–7 days.

Step 2: Complete W-8BEN

The W-8BEN certifies you are a non-US person — reduces dividend withholding from 30% to 15% under India-US DTAA. All Indian LRS platforms handle this during KYC.

Step 3: Fund via LRS remittance

Transfer INR from your Indian bank. Your bank converts to USD and remits as an LRS transfer (RBI Purpose Code S0001). Typically 1–3 business days to appear in your US brokerage.

TCS on remittance:

• First ₹10 lakh/year: 0% TCS
• Above ₹10 lakh/year: 20% TCS on the excess (advance tax credit — refundable at ITR filing)

Step 4: Buy ANT after listing

Search for ANT on your platform after NYSE trading begins. If the share price is high, use fractional shares on Vested or INDmoney.

Day 1 caution: IPO first-day prices are volatile. The stock may open significantly above or below the IPO price. There is no urgency to buy on listing day — the same shares are available on day 2, week 2, and month 2. The best tactical entry point is usually the lock-up expiry (90–180 days post-listing), when insider selling pressure peaks.

Pre-listing: indirect Anthropic exposure today

Alphabet is the most direct proxy: A 10% stake in a $2T company is worth ~$200B — roughly 9% of Alphabet's total market cap. If you believe Anthropic's valuation is fair, every dollar of GOOGL buys you ~9 cents of Anthropic exposure.

Amazon's exposure is more complex: AWS is Anthropic's cloud provider and an investor, but Amazon Nova models compete with Claude. Amazon's Anthropic stake is partly strategic to retain a major AWS customer.

Valuation analysis: is $2 trillion realistic?

At $2T and ~$4B ARR, Anthropic trades at roughly 500x revenue at IPO — a level no other public company in history has sustained at scale.

Bull case math (for $2T to work by 2030):

• Anthropic reaches ~$40B ARR — 10x current estimates
• Market prices it at 50x revenue (still very generous)
• 50x × $40B = $2T ✓

This requires 50%+ annual revenue growth sustained for 4 years, with no meaningful pricing compression.

Bear case math:

• AI commodity pricing (Meta's Llama open-source competes on price) keeps ARR at $12–15B by 2030
• Market prices at 20–30x revenue (more mature tech multiple)
• 25x × $13B = $325B — 84% below IPO valuation

Honest assessment: This is a venture-stage risk/reward packaged as a public market investment. The $2T valuation is aggressive even by 2026 AI standards. Appropriate as a small (<5%) speculative position for growth-oriented investors; not appropriate as a core holding or large allocation.

Tax treatment: buying and holding ANT

Capital gains

The currency component of your taxable gain:

The gain is computed in INR, not USD. Example:

• You buy $2,000 of ANT when USD/INR = 95 → INR cost = ₹1,90,000
• You sell at the same $2,000 USD price 3 years later when USD/INR = 110 → INR proceeds = ₹2,20,000
• Taxable LTCG = ₹30,000 at 12.5% = ₹3,750 tax

Real tax on a position that went nowhere in dollar terms. This is the currency component of Indian overseas investment taxation — plan for it in your return expectations.

Dividends

Anthropic is unlikely to pay dividends in the near term (loss-making, growth phase). If it does:

• Indian tax: taxed as income at slab rate
• US withholding: 30% default, reduced to 15% under India-US DTAA with valid W-8BEN

Schedule FA

Mandatory annual disclosure of ANT shares in ITR-2 Schedule FA while you hold them. Report: institution name (your LRS broker), account number, peak value during the year, closing value, income received. Non-disclosure carries penalties under FEMA and the Black Money Act.

Key risks

1. Valuation risk (highest)

500x revenue leaves almost no margin for error. Any slowdown in growth or margin compression triggers severe drawdowns.

2. Open-source competition

Meta's Llama models are free and improving rapidly. They create a pricing ceiling on what closed-source models like Claude can charge in developer markets. Anthropic's enterprise pricing holds better — regulated industries prefer the safety certifications — but the pressure is real.

3. Hyperscaler dependency

Anthropic runs almost entirely on AWS. Amazon is simultaneously an investor, the primary cloud provider, and a competitor (Amazon Nova models). If AWS terms change or Amazon competes more aggressively with Claude, Anthropic's cost structure and distribution are at risk.

4. Capital intensity

Training frontier AI models costs hundreds of millions to billions per run. As models scale, training costs increase. Anthropic needs continuous capital raises or profitability to stay competitive. As a public company, dilutive capital raises hit existing shareholders.

5. Lock-up expiry

90–180 days post-listing, insiders can begin selling. This typically suppresses the stock and creates the best post-IPO buying opportunity. If you are interested in ANT, consider waiting for the lock-up dump rather than buying at listing.

6. Regulatory risk

EU AI Act, US AI legislative proposals, and capability restrictions could affect Claude's deployment in regulated industries — Anthropic's main revenue differentiation.

What to track before and after listing

Should Indian investors buy ANT?

Sources

Figures last checked November 2026. Verify before investing — IPO details change before listing.

1. Anthropic public S-1 prospectus (filed October 26, 2026) — sec.gov/cgi-bin/browse-edgar (Nov 2026)
2. RBI LRS framework (Purpose Code S0001) — rbi.org.in/Scripts/FAQView.aspx?Id=115 (Nov 2026)
3. Income Tax Act — Section 112A (LTCG) and Section 111A (STCG) — incometax.gov.in (Nov 2026)
4. Income Tax Act — Section 206C(1G) (TCS on LRS) — incometax.gov.in (Nov 2026)
5. DTAA India-USA (dividend withholding Article 10) — incometax.gov.in (Nov 2026)
6. Schedule FA disclosure requirement (Black Money Act, 2015) — incometax.gov.in (Nov 2026)

Vested.blog is the editorial publication of Rovia.